CDK6 and cancer: JMJD2B has been shown to play a role in altering the expression of many cancer associated genes including cyclin-dependent kinase 6 (CDK6) (49), and carbonic anhydrase 9 (CA9) (50), which can directly affect the transmembrane pH gradient.